TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8440093

Group type: EXPERIMENTAL
Intervention: Data, Safety and Quality Review Group (DSQ) monitoring
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Creation of a free-standing operations manual for the DSQ
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Involvement of study investigators in developing the operations manual
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monitoring of scientific integrity and patient safety
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Confidence in study results
Number of subjects: 0
Study: 3816530

Group type: EXPERIMENTAL
Intervention: Positive incentive procedure (dose increase for drug-free urines)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Negative incentive procedure (dose decrease for drug-positive urines)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dose decrease condition
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dose increase condition
Number of subjects: 20
Study: 29326296

Group type: EXPERIMENTAL
Intervention: Intrathecal baclofen therapy (ITB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional medical management (CMM)
Number of subjects: 60
Study: 26573530

Group type: EXPERIMENTAL
Intervention: Paracervical block (PCB) with bupivacaine
Number of subjects: 113

Group type: COMPARATOR
Intervention: Paracervical block (PCB) with sodium chloride
Number of subjects: 113
Study: 25493129

Group type: EXPERIMENTAL
Intervention: 4S technique by ultrasound experts
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 4S technique by emergency medicine residents (EMRs)
Number of subjects: 150
Study: 22735431

Group type: COMPARATOR
Intervention: Standard Behavioral Weight Intervention (SBWI)
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Stepped-Care Weight Loss Intervention (STEP)
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Both groups (SBWI and STEP)
Number of subjects: 363
Study: 20636896

Group type: EXPERIMENTAL
Intervention: Elimination diet
Number of subjects: 21
Study: 17366357

Group type: EXPERIMENTAL
Intervention: Coronary artery disease confirmed based on history of myocardial infarction
Number of subjects: 2593

Group type: EXPERIMENTAL
Intervention: Coronary artery disease confirmed based on positive electrocardiographic stress test
Number of subjects: 2593

Group type: EXPERIMENTAL
Intervention: Coronary artery disease confirmed based on history of typical angina in subjects >60 years
Number of subjects: 2593

Group type: EXPERIMENTAL
Intervention: Coronary artery disease confirmed based on history of previous acute coronary syndrome
Number of subjects: 2593

Group type: EXPERIMENTAL
Intervention: Coronary artery disease confirmed based on PCI
Number of subjects: 2593

Group type: EXPERIMENTAL
Intervention: Coronary artery disease confirmed based on CABG
Number of subjects: 2593

Group type: EXPERIMENTAL
Intervention: Coronary artery disease confirmed based on positive coronary angiography
Number of subjects: 2593

Group type: EXPERIMENTAL
Intervention: Patients with diagnosed stable CAD with normal blood pressure
Number of subjects: 2593

Group type: EXPERIMENTAL
Intervention: Patients with normal LDL cholesterol concentrations (<3.36 mmol/L)
Number of subjects: 2593

Group type: EXPERIMENTAL
Intervention: Patients with metabolic syndrome diagnosed according to NCEP ATP III criteria
Number of subjects: 2593

Group type: EXPERIMENTAL
Intervention: Patients presenting symptoms of congestive heart failure
Number of subjects: 2593

Group type: EXPERIMENTAL
Intervention: Patients with rhythm or conduction disturbances (most commonly atrial fibrillation)
Number of subjects: 2593

Group type: EXPERIMENTAL
Intervention: Patients with previous stroke
Number of subjects: 2593

Group type: EXPERIMENTAL
Intervention: Patients with transient ischaemic attack
Number of subjects: 2593

Group type: EXPERIMENTAL
Intervention: Patients with peripheral artery disease
Number of subjects: 2593

Group type: EXPERIMENTAL
Intervention: Patients with asthma or COPD
Number of subjects: 2593
Study: 16307958

Group type: EXPERIMENTAL
Intervention: Face targets with solitary flanking distractor face
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Face targets with solitary flanking nonface stimulus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonface targets with solitary flanking distractor face
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonface targets with solitary flanking nonface stimulus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Four task-irrelevant flankers (distractor faces)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Four task-irrelevant flankers (nonface targets)
Number of subjects: 0
Study: 9796505

Group type: EXPERIMENTAL
Intervention: Experimental group with alum-containing mouthrinse
Number of subjects: 45

Group type: COMPARATOR
Intervention: Vehicle control group (mouthrinse without alum)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Treatment control (distilled water)
Number of subjects: 45
Study: 7808281

Group type: EXPERIMENTAL
Intervention: Encoding enactment (motor encoding and verbal test)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Retrieval enactment (verbal encoding and motor test)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dual enactment (motor encoding and motor test)
Number of subjects: 0
Study: 2548299

Group type: EXPERIMENTAL
Intervention: Almitrine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 811319

Group type: EXPERIMENTAL
Intervention: Tetracycline 500 mg four times a day for 7 days
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Tetracycline 250 mg four times a day for 14 days
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Deteclo 300 mg three times a day for 3 weeks
Number of subjects: 400

Group type: COMPARATOR
Intervention: Tetracycline 250 mg four times a day for 4 days
Number of subjects: 400
Study: 31164341

Group type: EXPERIMENTAL
Intervention: Olaparib maintenance therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28032333

Group type: EXPERIMENTAL
Intervention: α1-adrenergic blockade (prazosin; 0.05 mg kg -1)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 25788405

Group type: EXPERIMENTAL
Intervention: 20 g protein supplement, 10 times weekly during 13 weeks
Number of subjects: 60
Study: 24937976

Group type: EXPERIMENTAL
Intervention: Combination of vaginal progesterone (P) and 75 IU recombinant luteinizing hormone (rLH), 4 doses every 3 days, starting on the day of embryo transfer
Number of subjects: 47

Group type: COMPARATOR
Intervention: Luteal vaginal progesterone (P)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Combination of vaginal progesterone (P) and 75 IU recombinant luteinizing hormone (rLH)
Number of subjects: 47
Study: 22193727

Group type: EXPERIMENTAL
Intervention: Sibutramine (15 mg/d for 14 days)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sibutramine
Number of subjects: 10
Study: 20156958

Group type: EXPERIMENTAL
Intervention: Mortality review committee data
Number of subjects: 4

Group type: COMPARATOR
Intervention: Death certificate data
Number of subjects: 4
Study: 18042892

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.5% (30 mL)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo (isotonic saline)
Number of subjects: 79
Study: 15609378

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendicectomy (LA)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Open appendicectomy (OA)
Number of subjects: 163
Study: 14601471

Group type: EXPERIMENTAL
Intervention: Oral magnesium supplementation (Slow‐Mag B6) at 320 mg/day
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (hypertensive patients not treated pharmacologically)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Patients treated with diuretics
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Patients treated with Ca channel blockers
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Oral magnesium supplementation (Slow‐Mag B6)
Number of subjects: 92
Study: 10467795

Group type: EXPERIMENTAL
Intervention: 2 mg nalbuphine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 3 mg nalbuphine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 4 mg nalbuphine
Number of subjects: 90
Study: 7784339

Group type: EXPERIMENTAL
Intervention: Controlled release acetaminophen (paracetamol) tablet A
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Controlled release acetaminophen (paracetamol) tablet B
Number of subjects: 0

Group type: COMPARATOR
Intervention: In vitro profiles at paddle speed of 10 rpm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In vivo release rate in dogs
Number of subjects: 0
Study: 1995718

Group type: EXPERIMENTAL
Intervention: rgp160 vaccine
Number of subjects: 12

Group type: COMPARATOR
Intervention: recombinant hepatitis B vaccine
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 6084217

Group type: EXPERIMENTAL
Intervention: Feeder vessel photocoagulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control eyes
Number of subjects: 0
Study: 31028782

Group type: EXPERIMENTAL
Intervention: Chromoendoscopy (CE)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Conventional white-light endoscopy (WLE)
Number of subjects: 246
Study: 29684789

Group type: EXPERIMENTAL
Intervention: Bipedal hopping at 60 beats/min (bpm)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Bipedal hopping at 40 bpm
Number of subjects: 13

Group type: COMPARATOR
Intervention: Bipedal hopping at 60 bpm
Number of subjects: 13
Study: 26826179

Group type: EXPERIMENTAL
Intervention: Vorapaxar
Number of subjects: 3787

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3787
Study: 28159849

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 8
Study: 22963498

Group type: EXPERIMENTAL
Intervention: Controllable situation (knew the topic in advance)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Uncontrollable situation (impromptu speech)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Participants who believed in the benefits of worry
Number of subjects: 72
Study: 20663993

Group type: EXPERIMENTAL
Intervention: Eltrombopag
Number of subjects: 199
Study: 19436745

Group type: EXPERIMENTAL
Intervention: Mebendazole treatment every 3 months
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: Mebendazole treatment
Number of subjects: 666

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 666
Study: 16970950

Group type: EXPERIMENTAL
Intervention: Irbesartan (IRB) 300 mg per day
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 15461606

Group type: EXPERIMENTAL
Intervention: Parietaria pollen vaccine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 30
Study: 11287374

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients with Alzheimer's disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 9645412

Group type: EXPERIMENTAL
Intervention: 7.5 mg zopiclone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 7562123

Group type: EXPERIMENTAL
Intervention: tissue plasminogen activator (tPA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: streptokinase (SK)
Number of subjects: 0
Study: 2195579

Group type: EXPERIMENTAL
Intervention: Caffeine (3.5 mg/kg)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 110028

Group type: EXPERIMENTAL
Intervention: 2% DSCG eye drops
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo eye drops
Number of subjects: 30
Study: 31418022

Group type: EXPERIMENTAL
Intervention: 30 µg RSV-PreF vaccine
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: 60 µg RSV-PreF vaccine
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: 120 µg RSV-PreF vaccine
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 29351542

Group type: EXPERIMENTAL
Intervention: Anti-adhesion gel (hyaluronic acid-carboxymethylcellulose, Seprafilm®) applied locally during surgery
Number of subjects: 200

Group type: COMPARATOR
Intervention: No anti-adhesion gel applied (control group)
Number of subjects: 200
Study: 26147178

Group type: EXPERIMENTAL
Intervention: Illustrated leaflet and verbal instructions on oral hygiene and utilization habits
Number of subjects: 70

Group type: COMPARATOR
Intervention: Advice to continue cleaning and wearing new dentures as previous dentures
Number of subjects: 70
Study: 23369173

Group type: EXPERIMENTAL
Intervention: Observational learning (visual arts)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Observational learning (verbal arts)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Control condition (learning by practicing)
Number of subjects: 131
Study: 20802258

Group type: EXPERIMENTAL
Intervention: Rocking-chair group (RCG, n=26)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (CG, n=25)
Number of subjects: 51
Study: 19246610

Group type: EXPERIMENTAL
Intervention: Videoconferencing nutritional counselling (2 additional sessions at 4 and 8 weeks)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (single group education session via videoconference)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 32
Study: 16708735

Group type: EXPERIMENTAL
Intervention: PEG tube feeding
Number of subjects: 22

Group type: COMPARATOR
Intervention: NG tube feeding
Number of subjects: 22
Study: 15001627

Group type: EXPERIMENTAL
Intervention: Estradiol (E(2))
Number of subjects: 8
Study: 11689582

Group type: EXPERIMENTAL
Intervention: Perioperative chemotherapy (PeCT)
Number of subjects: 1275

Group type: COMPARATOR
Intervention: No adjuvant treatment
Number of subjects: 1275
Study: 9113215

Group type: EXPERIMENTAL
Intervention: Doctors Helping Smokers (DHS) model
Number of subjects: 601

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 601

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 601
Study: 7952453

Group type: EXPERIMENTAL
Intervention: Expanded polytetrafluoroethylene (ePTFE) patch
Number of subjects: 20

Group type: COMPARATOR
Intervention: Braided polyester tape
Number of subjects: 20
Study: 2356405

Group type: EXPERIMENTAL
Intervention: Nycotest‐Chrom (N‐test)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Thromboquant‐PT (Tbq)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Thrombotest (TT)
Number of subjects: 110
Study: 363486

Group type: EXPERIMENTAL
Intervention: Lisuride hydrogen maleate
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 31797385

Group type: EXPERIMENTAL
Intervention: Psychosocial stimulation intervention with weekly home visits for 18 months
Number of subjects: 421
Study: 31650270

Group type: EXPERIMENTAL
Intervention: Limbal conjunctival autograft (LCAU)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intraoperative mitomycin C (MMC) 0.02% for 5 min
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combined LCAU + MMC 0.02% for 5 min
Number of subjects: 40
Study: 28623848

Group type: EXPERIMENTAL
Intervention: Smoking-reduction intervention (SRI)
Number of subjects: 369

Group type: COMPARATOR
Intervention: Exercise and diet advice (EDA) control
Number of subjects: 369
Study: 25688159

Group type: EXPERIMENTAL
Intervention: anti‐CD3 × anti‐HER2 bispecific antibody (HER2Bi) armed anti‐CD3‐activated T cells (aATC)
Number of subjects: 23
Study: 23778295

Group type: EXPERIMENTAL
Intervention: Manual segmental FJ provocation tests (spinal percussion, springing, and segmental rotation tests) in subjects with LBP
Number of subjects: 150

Group type: COMPARATOR
Intervention: Manual segmental FJ provocation tests (spinal percussion, springing, and segmental rotation tests) in control subjects
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: MRI findings of effusion and/or edema in subjects with LBP
Number of subjects: 150

Group type: COMPARATOR
Intervention: MRI findings of effusion and/or edema in control subjects
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: True-positive findings in subjects with LBP
Number of subjects: 150

Group type: COMPARATOR
Intervention: True-positive findings in control subjects
Number of subjects: 150
Study: 21612140

Group type: EXPERIMENTAL
Intervention: Acute Normovolemic Hemodilution (ANH) group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (homologous blood transfusion)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 19275276

Group type: EXPERIMENTAL
Intervention: Transdermal oxybutynin 3.9 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transdermal oxybutynin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16717329

Group type: EXPERIMENTAL
Intervention: Erythromycin (250 mg infusion)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (saline infusion)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (saline infusion with 37 degrees C water immersion)
Number of subjects: 7
Study: 17115498

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 11322410

Group type: EXPERIMENTAL
Intervention: Bare-sclera procedure (group 1)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Bare-sclera with intraoperative mitomycin C (MMC 0.02% for 30 seconds; group 2)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Pterygium excision with conjunctival autografting (group 3)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (healthy fellow eyes and seven age- and sex-matched subjects)
Number of subjects: 38
Study: 9399764

Group type: EXPERIMENTAL
Intervention: Octreotide 50 microg s.c. t.i.d (n = 6)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (n = 6)
Number of subjects: 12
Study: 8421972

Group type: EXPERIMENTAL
Intervention: Invasive strategy
Number of subjects: 3339

Group type: COMPARATOR
Intervention: Conservative strategy
Number of subjects: 3339

Group type: EXPERIMENTAL
Intervention: Patients who did not perform the predischarge exercise test
Number of subjects: 3339

Group type: EXPERIMENTAL
Intervention: Patients who performed the predischarge exercise test
Number of subjects: 3339

Group type: EXPERIMENTAL
Intervention: Conservative strategy with exercise-induced ST-segment depression or chest pain
Number of subjects: 3339
Study: 3548811

Group type: EXPERIMENTAL
Intervention: Ivermectin (12 mg single dose on day 1, followed by placebo for 7 days)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine (DEC, total dose 1.3 g)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 29762818

Group type: EXPERIMENTAL
Intervention: Titanium Alloy (TiA) miniscrews
Number of subjects: 15

Group type: COMPARATOR
Intervention: Stainless Steel (SS) miniscrews
Number of subjects: 15
Study: 25880893

Group type: EXPERIMENTAL
Intervention: Reused phaco tip in torsional phacoemulsification
Number of subjects: 136

Group type: COMPARATOR
Intervention: Single use phaco tip in torsional phacoemulsification
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Reused phaco tip in transversal phacoemulsification
Number of subjects: 136

Group type: COMPARATOR
Intervention: Single use phaco tip in transversal phacoemulsification
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Both tip groups in torsional and transversal phacoemulsification
Number of subjects: 136
Study: 24745637

Group type: EXPERIMENTAL
Intervention: Long-lasting permethrin impregnated uniforms
Number of subjects: 159

Group type: COMPARATOR
Intervention: Sham treatment uniforms (Control)
Number of subjects: 159
Study: 24308874

Group type: EXPERIMENTAL
Intervention: New evidence-based smoking cessation service package
Number of subjects: 440

Group type: COMPARATOR
Intervention: Routine service package (5A approach)
Number of subjects: 440
Study: 20843990

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir monotherapy
Number of subjects: 186

Group type: COMPARATOR
Intervention: Current combined antiretroviral treatment (cART)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir monotherapy (with treatment intensification)
Number of subjects: 186
Study: 19042197

Group type: EXPERIMENTAL
Intervention: Pretreatment Readiness Scale (PRS)
Number of subjects: 367

Group type: COMPARATOR
Intervention: Texas Christian University‐Treatment Motivation Assessment (TCU‐TMA)
Number of subjects: 367
Study: 16029399

Group type: EXPERIMENTAL
Intervention: ROC 0.25 mg.kg(‐1)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 13129880

Group type: EXPERIMENTAL
Intervention: Phacoemulsification and foldable intraocular lens (IOL) implantation
Number of subjects: 21
Study: 10499748

Group type: EXPERIMENTAL
Intervention: 3 mL 1.5% lidocaine plus epinephrine 15 microg (1/200,000)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 3 mL normal saline
Number of subjects: 40
Study: 8711613

Group type: EXPERIMENTAL
Intervention: Ultracision Harmonic Scalpel LCS (LCS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Multifire clip applier (MCA) and sharp division
Number of subjects: 20
Study: 1800468

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl, 5 micrograms/mL
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl, 5 micrograms/mL with 0.75% solution of lidocaine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl, 5 micrograms/mL with 1.0% solution of lidocaine
Number of subjects: 15

Group type: COMPARATOR
Intervention: All groups (including control)
Number of subjects: 15
Study: 6344982

Group type: COMPARATOR
Intervention: Doxorubicin-CCNU
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Doxorubicin-CCNU-Vincristine (VCR)
Number of subjects: 35
Study: 31007108

Group type: EXPERIMENTAL
Intervention: Cervicitis agents screening using multiplex PCR
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Cervicitis presence
Number of subjects: 133
Study: 30382904

Group type: EXPERIMENTAL
Intervention: Wei nasal jet tube (WNJT)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Nasal prongs
Number of subjects: 308
Study: 27578574

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training followed by non-invasive positive pressure ventilation (IMT-NPPV group)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training only (IMT group)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Non-invasive positive pressure ventilation only (NPPV group)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Oxygen therapy (control group)
Number of subjects: 88